Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial
- Author
- MORRISSEY, C. Orla1 11 ; CHEN, Sharon C.-A2 4 ; SCHWARER, Anthony P9 ; GUY, Stephen10 ; BAJEL, Ashish7 ; TRAMONTANA, Adrian R10 ; SPELMAN, Timothy11 12 ; SLAVIN, Monica A11 13 7 ; SORRELL, Tania C2 4 ; MILLIKEN, Samuel5 ; BARDY, Peter G6 ; BRADSTOCK, Kenneth F3 ; SZER, Jeffrey7 ; HALLIDAY, Catriona L2 ; GILROY, Nicole M8 ; MOORE, John5
[1] Infectious Diseases Unit, Alfred Health, and Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, Australia
[2] Centre for Infectious Diseases and Microbiology, Westmead Hospital, Westmead, NSW, Australia
[3] Department of Haematology, Westmead Hospital, Westmead, NSW, Australia
[4] Westmead Millennium Institute, Westmead, and Western Clinical School and Sydney Emerging Infections and Biosecurity Institute, University of Sydney, Sydney, NSW, Australia
[5] Department of Haematology, Saint Vincent's Hospital, Darlinghurst, NSW, Australia
[6] Department of Haematology, Royal Adelaide Hospital, Adelaide, and Department of Haematology, The Queen Elizabeth Hospital, Woodville South, SA, Australia
[7] Department of Clinical Haematology and Bone Marrow Transplant Service, Royal Melbourne Hospital, Parkville, VIC, Australia
[8] New South Wales Bone Marrow Transplant Network, Agency for Clinical Innovation, Chatswood, NSW, Australia
[9] Department of Haematology, Alfred Health, Melbourne, and Department of Haematology and Medical Oncology, Box Hill Hospital, Box Hill, VIC, Australia
[10] Department of Infectious Diseases, Western Health, Footscray, VIC, Australia
[11] Burnet Institute, Melbourne, VIC, Australia
[12] Department of Epidemiology and Preventative Medicine, Central Clinical School, Monash University, Melbourne, VIC, Australia
[13] Peter MacCallum Cancer Centre, East Melbourne, and National Health and Medical Research Council Centre for Clinical Research Excellence in Infectious Diseases, Royal Melbourne Hospital, Parkville, VIC, Australia
Australasian Leukaemia Lymphoma Group, Australia - Source
Lancet. Infectious diseases (print). 2013, Vol 13, Num 6, pp 519-528, 10 p ; ref : 35 ref
- ISSN
- 1473-3099
- Scientific domain
- General medicine general surgery; Microbiology, infectious diseases
- Publisher
- Lancet Publishing Group, London
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antifongique Aspergillose Etude comparative Galactomannane Histologie Homme Risque élevé Réaction chaîne polymérase Traitement Forme invasive Biologie moléculaire Infection Mycose
- Keyword (en)
- Antifungal agent Aspergillosis Comparative study Galactomannan Histology Human High risk Polymerase chain reaction Treatment Molecular biology Infection Mycosis
- Keyword (es)
- Antifúngico Aspergilosis Estudio comparativo Galactómanano Histología Hombre Riesgo alto Reacción cadena polimerasa Tratamiento Biología molecular Infección Micosis
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S04 Antifungal agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05D Mycoses / 002B05D02 Human mycoses / 002B05D02L Miscellaneous mycoses
- Discipline
- Infectious pathology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27407466
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/S1473-3099(13)70076-8 
https://dx.doi.org/10.1016/S1473-3099(13)70076-8
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S1473-3099(13)70076-8\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:184:\"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Lancet. Infectious diseases (print)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Lancet. Infect. dis. (print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"13\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"519\";s:8:\"\u0000*\u0000epage\";s:3:\"528\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1473-3099\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"MORRISSEY\";s:10:\"\u0000*\u0000aufirst\";s:7:\"C. Orla\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:17:\"CHEN, Sharon C.-A\";i:1;s:19:\"SCHWARER, Anthony P\";i:2;s:12:\"GUY, Stephen\";i:3;s:13:\"BAJEL, Ashish\";i:4;s:20:\"TRAMONTANA, Adrian R\";i:5;s:16:\"SPELMAN, Timothy\";i:6;s:16:\"SLAVIN, Monica A\";i:7;s:16:\"SORRELL, Tania C\";i:8;s:16:\"MILLIKEN, Samuel\";i:9;s:14:\"BARDY, Peter G\";i:10;s:20:\"BRADSTOCK, Kenneth F\";i:11;s:13:\"SZER, Jeffrey\";i:12;s:20:\"HALLIDAY, Catriona L\";i:13;s:16:\"GILROY, Nicole M\";i:14;s:11:\"MOORE, John\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:184:\"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:23:\"Lancet Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S1473-3099(13)70076-8\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:184:\"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Lancet. Infectious diseases (print)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Lancet. Infect. dis. (print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"13\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"519\";s:8:\"\u0000*\u0000epage\";s:3:\"528\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1473-3099\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"MORRISSEY\";s:10:\"\u0000*\u0000aufirst\";s:7:\"C. Orla\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:17:\"CHEN, Sharon C.-A\";i:1;s:19:\"SCHWARER, Anthony P\";i:2;s:12:\"GUY, Stephen\";i:3;s:13:\"BAJEL, Ashish\";i:4;s:20:\"TRAMONTANA, Adrian R\";i:5;s:16:\"SPELMAN, Timothy\";i:6;s:16:\"SLAVIN, Monica A\";i:7;s:16:\"SORRELL, Tania C\";i:8;s:16:\"MILLIKEN, Samuel\";i:9;s:14:\"BARDY, Peter G\";i:10;s:20:\"BRADSTOCK, Kenneth F\";i:11;s:13:\"SZER, Jeffrey\";i:12;s:20:\"HALLIDAY, Catriona L\";i:13;s:16:\"GILROY, Nicole M\";i:14;s:11:\"MOORE, John\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:184:\"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:23:\"Lancet Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S1473-3099(13)70076-8\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S1473-3099(13)70076-8\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:184:\"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Lancet. Infectious diseases (print)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Lancet. Infect. dis. (print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"13\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"519\";s:8:\"\u0000*\u0000epage\";s:3:\"528\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1473-3099\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"MORRISSEY\";s:10:\"\u0000*\u0000aufirst\";s:7:\"C. Orla\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:17:\"CHEN, Sharon C.-A\";i:1;s:19:\"SCHWARER, Anthony P\";i:2;s:12:\"GUY, Stephen\";i:3;s:13:\"BAJEL, Ashish\";i:4;s:20:\"TRAMONTANA, Adrian R\";i:5;s:16:\"SPELMAN, Timothy\";i:6;s:16:\"SLAVIN, Monica A\";i:7;s:16:\"SORRELL, Tania C\";i:8;s:16:\"MILLIKEN, Samuel\";i:9;s:14:\"BARDY, Peter G\";i:10;s:20:\"BRADSTOCK, Kenneth F\";i:11;s:13:\"SZER, Jeffrey\";i:12;s:20:\"HALLIDAY, Catriona L\";i:13;s:16:\"GILROY, Nicole M\";i:14;s:11:\"MOORE, John\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:184:\"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:23:\"Lancet Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S1473-3099(13)70076-8\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:184:\"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Lancet. Infectious diseases (print)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Lancet. Infect. dis. (print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"13\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"519\";s:8:\"\u0000*\u0000epage\";s:3:\"528\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1473-3099\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"MORRISSEY\";s:10:\"\u0000*\u0000aufirst\";s:7:\"C. Orla\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:17:\"CHEN, Sharon C.-A\";i:1;s:19:\"SCHWARER, Anthony P\";i:2;s:12:\"GUY, Stephen\";i:3;s:13:\"BAJEL, Ashish\";i:4;s:20:\"TRAMONTANA, Adrian R\";i:5;s:16:\"SPELMAN, Timothy\";i:6;s:16:\"SLAVIN, Monica A\";i:7;s:16:\"SORRELL, Tania C\";i:8;s:16:\"MILLIKEN, Samuel\";i:9;s:14:\"BARDY, Peter G\";i:10;s:20:\"BRADSTOCK, Kenneth F\";i:11;s:13:\"SZER, Jeffrey\";i:12;s:20:\"HALLIDAY, Catriona L\";i:13;s:16:\"GILROY, Nicole M\";i:14;s:11:\"MOORE, John\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:184:\"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:23:\"Lancet Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S1473-3099(13)70076-8\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:184:\"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Lancet. Infectious diseases (print)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Lancet. Infect. dis. (print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"13\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"519\";s:8:\"\u0000*\u0000epage\";s:3:\"528\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1473-3099\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"MORRISSEY\";s:10:\"\u0000*\u0000aufirst\";s:7:\"C. Orla\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:17:\"CHEN, Sharon C.-A\";i:1;s:19:\"SCHWARER, Anthony P\";i:2;s:12:\"GUY, Stephen\";i:3;s:13:\"BAJEL, Ashish\";i:4;s:20:\"TRAMONTANA, Adrian R\";i:5;s:16:\"SPELMAN, Timothy\";i:6;s:16:\"SLAVIN, Monica A\";i:7;s:16:\"SORRELL, Tania C\";i:8;s:16:\"MILLIKEN, Samuel\";i:9;s:14:\"BARDY, Peter G\";i:10;s:20:\"BRADSTOCK, Kenneth F\";i:11;s:13:\"SZER, Jeffrey\";i:12;s:20:\"HALLIDAY, Catriona L\";i:13;s:16:\"GILROY, Nicole M\";i:14;s:11:\"MOORE, John\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:184:\"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:23:\"Lancet Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
